Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

839
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
839
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

1.2K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.2K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

680
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
680
Bipolar Junction Transistor01:22

Bipolar Junction Transistor

1.5K
Bipolar Junction Transistors (BJTs) are essential elements in electronic circuits, playing a crucial role in the functionality of amplifiers, memories, and microprocessors. These transistors can be designed as NPN or PNP based on their doping patterns. They consist of three layers: the emitter, base, and collector. The configuration of these layers and their respective doping levels—with N-type or P-type impurities—define the transistor's type and its operational...
1.5K
Intrinsically Disordered Proteins02:18

Intrinsically Disordered Proteins

19.6K
Intrinsically disordered proteins are a group of proteins that do not fold into specific three-dimensional structures. Their structural flexibility allows them to complement ordered proteins to perform functions that are inaccessible to rigid structures. They are more common in eukaryotes than prokaryotes and may either be exclusively intrinsically disordered or hybrid proteins, consisting of a mix of ordered and disordered regions. The absence of a rigid structure in these proteins can be...
19.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing anandamide signalling through fatty acid amide hydrolase inhibition: An update on the pharmacological strategy for treating psychiatric disorders.

Translational psychiatry·2026
Same author

Correction: Cannabidiol and its Potential Evidence-Based Psychiatric Benefits - A Critical Review.

Pharmacopsychiatry·2026
Same author

Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them.

The American journal of psychiatry·2025
Same author

Cerebrospinal fluid metabolomics in autistic regression reveals dysregulation of sphingolipids and decreased β-hydroxybutyrate.

EBioMedicine·2025
Same author

Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers.

BMJ mental health·2024
Same author

Alterations to sphingolipid metabolism from antipsychotic administration in healthy volunteers are restored following the use of cannabidiol.

Psychiatry research·2024
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
Same journal

[In process].

Medizinische Monatsschrift fur Pharmazeuten·2018
See all related articles

Related Experiment Video

Updated: Feb 8, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.4K

Bipolar disorder: clinical overview.

Juliane K Müller, F Markus Leweke

    Medizinische Monatsschrift Fur Pharmazeuten
    |June 30, 2018
    PubMed
    Summary
    This summary is machine-generated.

    Bipolar disorder is a serious mental health condition affecting 1-2% of people, with subtypes like Bipolar I and Bipolar II. Its prognosis depends on individual factors and comorbidities.

    More Related Videos

    Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder
    06:54

    Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder

    Published on: March 4, 2018

    14.8K
    Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
    08:25

    Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment

    Published on: December 6, 2024

    1.3K

    Related Experiment Videos

    Last Updated: Feb 8, 2026

    Developing a Rat Model for Bipolar Disorder
    04:42

    Developing a Rat Model for Bipolar Disorder

    Published on: May 2, 2025

    1.4K
    Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder
    06:54

    Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder

    Published on: March 4, 2018

    14.8K
    Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
    08:25

    Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment

    Published on: December 6, 2024

    1.3K

    Area of Science:

    • Psychiatry
    • Neurology

    Background:

    • Bipolar disorder is a severe psychiatric condition with depressive, manic, and mixed episodes.
    • It affects 1-2% of the population, with subtypes like Bipolar I and Bipolar II.
    • Classification varies based on episode severity and frequency, including rapid cycling and cyclothymia.

    Purpose of the Study:

    • To provide an overview of bipolar disorder, its subtypes, and diagnostic considerations.
    • To highlight the impact of comorbidities on the illness course and prognosis.

    Main Methods:

    • Psychiatric and neurological examinations are crucial for diagnosis.
    • Clinical tests are necessary to exclude differential diagnoses, including other psychiatric, neurological, and somatic diseases.

    Main Results:

    • Bipolar I affects genders equally; Bipolar II is more common in women.
    • Rapid cycling involves over 4 episodes annually; cyclothymia features milder symptoms over two years.
    • Comorbidities and psychotic symptoms negatively influence the prognosis.

    Conclusions:

    • Accurate diagnosis and management of comorbidities are essential for improving bipolar disorder outcomes.
    • Prognosis is highly individualized and influenced by the illness's course and associated conditions.